Literature DB >> 12403341

Genetic influences on rheumatoid arthritis in African Americans.

Laura B Hughes1, Larry W Moreland, S Louis Bridges.   

Abstract

Rheumatoid arthritis is a common autoimmune disease characterized by inflammation of the synovial membrane of diarthrodial joints, which often leads to joint damage and disability. There are known associations between major histocompatibility complex class II alleles and susceptibility to rheumatoid arthritis and its severity in Caucasians. African Americans, an admixed population in the United States, has been underrepresented in genetic studies of the susceptibility and severity of rheumatoid arthritis. With the advent of biologic agents, which target specific molecules of the immune system (e.g., tumor necrosis factor, interleukin-1), biologic markers of treatment response in Caucasians and in African Americans would be clinically useful.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12403341     DOI: 10.1385/IR:26:1-3:015

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  83 in total

1.  A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure.

Authors:  Eric J Eichhorn; Michael J Domanski; Heidi Krause-Steinrauf; Michael R Bristow; Philip W Lavori
Journal:  N Engl J Med       Date:  2001-05-31       Impact factor: 91.245

2.  Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.

Authors:  P E Lipsky; D M van der Heijde; E W St Clair; D E Furst; F C Breedveld; J R Kalden; J S Smolen; M Weisman; P Emery; M Feldmann; G R Harriman; R N Maini
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

3.  HLA-linked rheumatoid arthritis.

Authors:  S J Hasstedt; D O Clegg; L Ingles; R H Ward
Journal:  Am J Hum Genet       Date:  1994-10       Impact factor: 11.025

4.  HLA-DR4 in Negro and Mexican rheumatoid arthritis patients.

Authors:  Y Ueno; Y Iwaki; P I Terasaki; M S Park; E V Barnett; D Chia; S Nakata
Journal:  J Rheumatol       Date:  1981 Sep-Oct       Impact factor: 4.666

5.  Patterns of radiological progression in early rheumatoid arthritis: results of an 8 year prospective study.

Authors:  M J Plant; P W Jones; J Saklatvala; W E Ollier; P T Dawes
Journal:  J Rheumatol       Date:  1998-03       Impact factor: 4.666

6.  Genetic variability in the tumor necrosis factor-lymphotoxin region influences susceptibility to rheumatoid arthritis.

Authors:  B Mulcahy; F Waldron-Lynch; M F McDermott; C Adams; C I Amos; D K Zhu; R H Ward; D O Clegg; F Shanahan; M G Molloy; F O'Gara
Journal:  Am J Hum Genet       Date:  1996-09       Impact factor: 11.025

7.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.

Authors:  A G Wilson; J A Symons; T L McDowell; H O McDevitt; G W Duff
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

8.  The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.

Authors:  D Fishman; G Faulds; R Jeffery; V Mohamed-Ali; J S Yudkin; S Humphries; P Woo
Journal:  J Clin Invest       Date:  1998-10-01       Impact factor: 14.808

9.  "Homozygosity" for the HLA-DR shared epitope contributes the highest risk for rheumatoid arthritis concordance in identical twins.

Authors:  D Jawaheer; W Thomson; A J MacGregor; D Carthy; J Davidson; P A Dyer; A J Silman; W E Ollier
Journal:  Arthritis Rheum       Date:  1994-05

10.  Association of HLA-DRw4 with rheumatoid arthritis in black and white patients.

Authors:  R W Karr; G E Rodey; T Lee; B D Schwartz
Journal:  Arthritis Rheum       Date:  1980-11
View more
  1 in total

1.  Epidemiologic analysis of racial/ethnic disparities: some fundamental issues and a cautionary example.

Authors:  Jay S Kaufman
Journal:  Soc Sci Med       Date:  2008-01-14       Impact factor: 4.634

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.